A detailed history of Northern Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Northern Capital Management, Inc. holds 238 shares of LLY stock, worth $189,369. This represents 0.13% of its overall portfolio holdings.

Number of Shares
238
Previous 238 -0.0%
Holding current value
$189,369
Previous $215,000 2.33%
% of portfolio
0.13%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $172,519 - $216,351
238 New
238 $215,000
Q4 2021

Jan 13, 2022

BUY
$224.85 - $279.04 $167,063 - $207,326
743 New
743 $205,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northern Capital Management, Inc. Portfolio

Follow Northern Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northern Capital Management, Inc. with notifications on news.